OSE Immunotherapeutics SA (EPA:OSE)

OSE Immunotherapeutics Revenue

In the year 2024, OSE Immunotherapeutics had annual revenue of 83.44 million EUR with 3,646.52% growth. OSE Immunotherapeutics had revenue of 862 thousand in the half year ending December 31, 2024, a decrease of -61.77%.

• Revenue: 83.44M
• Revenue Growth: +3,646.52%
• P/S Ratio: 1.62
• Revenue / Employee: 1.30M
• Employees: 64
• Market Cap: 135.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	83.44M	81.21M	3,646.52%
Dec 31, 2023	2.23M	-16.08M	-87.83%
Dec 31, 2022	18.30M	-8.00M	-30.43%
Dec 31, 2021	26.31M	15.89M	152.48%
Dec 31, 2020	10.42M	-15.53M	-59.85%